New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
07:02 EDTATRSAntares Pharma announces publication of three abstracts
Antares Pharma announced the publication of three abstracts at this year’s European League against Rheumatism Annual Congress being held in Paris, France on June 11 through June 14.In partnership with clinical researchers in the United States and Europe, Antares Pharma, the maker of OTREXUP for subcutaneous injection, supports original research intended to better understand the clinical role of subcutaneous methotrexate in the treatment of rheumatoid arthritis. Researchers from Switzerland, the United Kingdom, and the United States Veterans Administration will present original research at EULAR supported by unrestricted grants from Antares Pharma.
News For ATRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2015
16:21 EDTATRSAntares Pharma gets written notice of termination of agreement from Pfizer
On December 12, 2011, Antares Pharma (ATRS) entered into a licensing agreement with Pfizer (PFE) Consumer Healthcare for one of our drug delivery technologies to develop an undisclosed product on an exclusive basis for North America. On October 5, the Company received a written notice of termination of the Agreement from Pfizer. Pfizer informed the Company that the product Pfizer was developing failed to meet pre-specified endpoints in a clinical study. Accordingly, the Agreement will terminate on November 5.
September 28, 2015
07:12 EDTATRSAntares announces publication of QuickShot Testosterone data in health journal
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use